Takashi Harano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Takashi Harano has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Scott M. Atay
Department of Surgery Division of Thoracic Surgery, Keck School of Medicine of USC Los Angeles California USA
9 shared publicationsSean C. Wightman
Department of Surgery Division of Thoracic Surgery, Keck School of Medicine of USC Los Angeles California USA
9 shared publicationsAnthony W. Kim
Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California
8 shared publicationsGraeme M. Rosenberg
Department of Surgery Division of Thoracic Surgery, Keck School of Medicine of USC Los Angeles California USA
7 shared publicationsBrooks V. Udelsman
Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California
5 shared publicationsMatthew R. Morrell
Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
5 shared publications
Latest Publications
- 18 August 2026
- Published by Wiley in Journal of Surgical Oncology
Determinants of Failure to Rescue After Pulmonary Resection for Lung Cancer: Insights From a National Inpatient Sample
Background and Objectives: Failure to rescue (FTR), defined as death following a postoperative complication, is an established quality metric; however, national data after pulmonary resection remain limited. We aim to identify patient‐, procedural‐, and hospital‐level factors associated with FTR after pulmonary resection for lung cancer and evaluate related outcomes. Methods: The National Inpatient Sample (2016–2022) was used to identify adults undergoing elective pulmonary resection for lung cancer who developed ≥ 1 major complication. FTR was defined as in‐hospital mortality. Multivariable logistic regression identified predictors. Secondary outcomes included length of stay, costs, and discharge disposition. Results: Among 14,575 patients with major complications, FTR occurred in 2.6%. Frailty (OR 3.44, 95% CI 2.73–4.35) and comorbidity burden (Elixhauser ≥ 2: OR 4.87, 1.54–15.43) were the strongest predictors. Pneumonectomy (OR 2.78, 1.82–4.23), age ≥ 75 years (OR 2.21, 1.47–3.32), and open approach (OR 1.78, 1.41–2.24) were also associated, while female sex and private insurance were protective. No hospital factors were independently associated. Conclusions: FTR is driven by patient vulnerability and procedural complexity rather than hospital characteristics. These findings emphasize preoperative risk stratification and complication management in high‐risk patients but do not support regionalization to high‐volume centers as a strategy to reduce FTR.
- 18 August 2026
- Published by Wiley in Journal of Surgical Oncology
Determinants of Failure to Rescue After Pulmonary Resection for Lung Cancer: Insights From a National Inpatient Sample
Background and Objectives: Failure to rescue (FTR), defined as death following a postoperative complication, is an established quality metric; however, national data after pulmonary resection remain limited. We aim to identify patient‐, procedural‐, and hospital‐level factors associated with FTR after pulmonary resection for lung cancer and evaluate related outcomes. Methods: The National Inpatient Sample (2016–2022) was used to identify adults undergoing elective pulmonary resection for lung cancer who developed ≥ 1 major complication. FTR was defined as in‐hospital mortality. Multivariable logistic regression identified predictors. Secondary outcomes included length of stay, costs, and discharge disposition. Results: Among 14,575 patients with major complications, FTR occurred in 2.6%. Frailty (OR 3.44, 95% CI 2.73–4.35) and comorbidity burden (Elixhauser ≥ 2: OR 4.87, 1.54–15.43) were the strongest predictors. Pneumonectomy (OR 2.78, 1.82–4.23), age ≥ 75 years (OR 2.21, 1.47–3.32), and open approach (OR 1.78, 1.41–2.24) were also associated, while female sex and private insurance were protective. No hospital factors were independently associated. Conclusions: FTR is driven by patient vulnerability and procedural complexity rather than hospital characteristics. These findings emphasize preoperative risk stratification and complication management in high‐risk patients but do not support regionalization to high‐volume centers as a strategy to reduce FTR.
- 16 June 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (8) , 2085-2091
Five Major Advancements in Thoracic Surgery Over the Past 50 Years
- 16 June 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (8) , 2085-2091
Five Major Advancements in Thoracic Surgery Over the Past 50 Years
- Open Access
Lung transplant outcomes in recipients waitlisted for both single and double lung transplantation
- 10 October 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 121 (4) , 961-970
The Impact of Kidney Transplantation on Survival Outcomes for Lung Transplantation
- 10 October 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 121 (4) , 961-970
The Impact of Kidney Transplantation on Survival Outcomes for Lung Transplantation
- 28 January 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (2) , e70096
Impact of Ex Vivo Lung Perfusion on Inpatient Cost: A Propensity Score‐Matched Analysis of the US Nationwide Healthcare Cost and Utilization Project Database
Background: The goal of this study was to investigate the association between ex vivo lung perfusion (EVLP) use and inpatient hospitalization cost for lung transplantation in a nationwide sample.Methods: Lung transplantation patients in 2018–2020 Nationwide Readmissions Database (NRD) were grouped based on use of EVLP. The primary outcome was total inpatient hospitalization cost. 1:2 propensity score matching by EVLP status was performed followed by multivariable linear regression to determine the association between inpatient cost and EVLP while adjusting for pre‐transplant hospital days, high volume EVLP center status, and propensity score.Results: There were 3902 lung transplants and 118 (3%) were recipients of EVLP lungs. Among EVLP patients, the median cost was $871 468 (IQR: $608 671–1 274 392), compared to $846 516 (IQR: $531 462–1 439 267, p = 0.871) among the total non‐EVLP cohort. After 1:2 propensity score‐matched cohort, recipients of EVLP lungs had longer median hospital length of stay (p = 0.046). In the multivariable model using the matched sample, increased cost was not associated with EVLP use (p = 0.783); however, high volume EVLP centers were associated with decreased cost (p = 0.018).Conclusions: EVLP use was not associated with greater inpatient costs and may be favorable at high volume centers.
- 28 January 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (2) , e70096
Impact of Ex Vivo Lung Perfusion on Inpatient Cost: A Propensity Score‐Matched Analysis of the US Nationwide Healthcare Cost and Utilization Project Database
Background: The goal of this study was to investigate the association between ex vivo lung perfusion (EVLP) use and inpatient hospitalization cost for lung transplantation in a nationwide sample.Methods: Lung transplantation patients in 2018–2020 Nationwide Readmissions Database (NRD) were grouped based on use of EVLP. The primary outcome was total inpatient hospitalization cost. 1:2 propensity score matching by EVLP status was performed followed by multivariable linear regression to determine the association between inpatient cost and EVLP while adjusting for pre‐transplant hospital days, high volume EVLP center status, and propensity score.Results: There were 3902 lung transplants and 118 (3%) were recipients of EVLP lungs. Among EVLP patients, the median cost was $871 468 (IQR: $608 671–1 274 392), compared to $846 516 (IQR: $531 462–1 439 267, p = 0.871) among the total non‐EVLP cohort. After 1:2 propensity score‐matched cohort, recipients of EVLP lungs had longer median hospital length of stay (p = 0.046). In the multivariable model using the matched sample, increased cost was not associated with EVLP use (p = 0.783); however, high volume EVLP centers were associated with decreased cost (p = 0.018).Conclusions: EVLP use was not associated with greater inpatient costs and may be favorable at high volume centers.
- 30 September 2024
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 169 (5) , 1398-1406.e2
Outcomes of single-lung retransplantation after double-lung transplantation
- 30 September 2024
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 169 (5) , 1398-1406.e2
Outcomes of single-lung retransplantation after double-lung transplantation
- Open Access
- 5 July 2024
- Published by Elsevier in JTCVS Techniques
- Vol. 27, 172-175
Esophageal perforation secondary to esophageal gastrointestinal stromal tumor
- 5 July 2024
- Published by Elsevier in JTCVS Techniques
- Vol. 27, 172-175
Open AccessEsophageal perforation secondary to esophageal gastrointestinal stromal tumor
- Open Access
- 1 June 2024
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 9, 14
The role of minimally invasive approaches in the management of pulmonary metastases
The role of minimally invasive approaches in the management of pulmonary metastases
- 1 June 2024
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 9, 14
Open AccessThe role of minimally invasive approaches in the management of pulmonary metastases
The role of minimally invasive approaches in the management of pulmonary metastases
- Open Access
- 1 June 2024
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 9, 20
A narrative review of minimally invasive pulmonary metastasectomy for colorectal cancer
Background and Objective: Pulmonary metastasectomy is a well-established intervention for the treatment of lung metastases from colorectal cancer (CRC). While minimally invasive approaches are used widely for this operation, the benefits and disadvantages of video-assisted thoracoscopic surgery (VATS) compared to open thoracotomy have not been thoroughly analyzed in the literature. Specifically, favorable prognostic factors and risk factors for pulmonary metastasectomy in the setting of VATS as well as benefits of repeat metastasectomy for recurrent lung metastasis using VATS compared to an open approach have yet to be explored. The aim of this study is to provide perspective on these specific topics, by reviewing the literature to compare advantages and outcomes of VATS vs. open thoracotomy. Methods: A literature search was performed using the PubMed database up to March 2023 for studies reporting on minimally invasive pulmonary metastasectomy for the treatment of lung metastases in CRC. Articles that were published in languages other than English were excluded. Full texts of potentially eligible articles were reviewed, and eligible studies were selected for inclusion of their reported results in this manuscript. Key Content and Findings: Several factors including number and size of pulmonary lesions, pre-operative serum carcinoembryonic antigen (CEA) level, length of disease-free interval (DFI), and mediastinal lymph node status were identified in the literature as being notable independent prognostic factors for post-metastasectomy outcomes, while prior extrapulmonary metastases (EPM) and anatomic resection were reported to be associated with high risk of metastatic recurrence of disease. For repeat metastasectomy for recurrent lung metastasis, VATS was shown to be equal or superior to open thoracotomy, due to decreased adhesion formation, decreased postoperative pain, shorter hospital length of stay, and improved compliance with adjuvant therapies. Conclusions: Despite a likely negligible survival benefit, VATS can be considered a favorable method of surgical intervention for the treatment of lung metastases in colorectal carcinoma for its advantages in patient quality of life and in cases of potential re-operation.
- 1 June 2024
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 9, 20
Open AccessA narrative review of minimally invasive pulmonary metastasectomy for colorectal cancer
Background and Objective: Pulmonary metastasectomy is a well-established intervention for the treatment of lung metastases from colorectal cancer (CRC). While minimally invasive approaches are used widely for this operation, the benefits and disadvantages of video-assisted thoracoscopic surgery (VATS) compared to open thoracotomy have not been thoroughly analyzed in the literature. Specifically, favorable prognostic factors and risk factors for pulmonary metastasectomy in the setting of VATS as well as benefits of repeat metastasectomy for recurrent lung metastasis using VATS compared to an open approach have yet to be explored. The aim of this study is to provide perspective on these specific topics, by reviewing the literature to compare advantages and outcomes of VATS vs. open thoracotomy. Methods: A literature search was performed using the PubMed database up to March 2023 for studies reporting on minimally invasive pulmonary metastasectomy for the treatment of lung metastases in CRC. Articles that were published in languages other than English were excluded. Full texts of potentially eligible articles were reviewed, and eligible studies were selected for inclusion of their reported results in this manuscript. Key Content and Findings: Several factors including number and size of pulmonary lesions, pre-operative serum carcinoembryonic antigen (CEA) level, length of disease-free interval (DFI), and mediastinal lymph node status were identified in the literature as being notable independent prognostic factors for post-metastasectomy outcomes, while prior extrapulmonary metastases (EPM) and anatomic resection were reported to be associated with high risk of metastatic recurrence of disease. For repeat metastasectomy for recurrent lung metastasis, VATS was shown to be equal or superior to open thoracotomy, due to decreased adhesion formation, decreased postoperative pain, shorter hospital length of stay, and improved compliance with adjuvant therapies. Conclusions: Despite a likely negligible survival benefit, VATS can be considered a favorable method of surgical intervention for the treatment of lung metastases in colorectal carcinoma for its advantages in patient quality of life and in cases of potential re-operation.